Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market
January 28, 2021 16:02 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...